| Primary |
| Hypertension |
12.2% |
| Thrombotic Thrombocytopenic Purpura |
12.2% |
| Cerebral Infarction |
11.0% |
| Angina Pectoris |
8.7% |
| Cerebrovascular Accident Prophylaxis |
6.4% |
| Myocardial Infarction |
5.2% |
| Atrial Fibrillation |
4.7% |
| Coronary Arterial Stent Insertion |
4.7% |
| Anticoagulant Therapy |
4.1% |
| Interstitial Lung Disease |
4.1% |
| Antiphospholipid Syndrome |
3.5% |
| Hyperlipidaemia |
3.5% |
| Thrombosis Prophylaxis |
3.5% |
| Benign Prostatic Hyperplasia |
2.3% |
| Constipation |
2.3% |
| Diabetes Mellitus |
2.3% |
| Hypoplastic Left Heart Syndrome |
2.3% |
| Insomnia |
2.3% |
| Myocardial Ischaemia |
2.3% |
| Prophylaxis |
2.3% |
|
| Thrombocytopenia |
13.0% |
| Shock Haemorrhagic |
9.3% |
| Small Intestine Ulcer |
7.4% |
| Cerebral Haemorrhage |
5.6% |
| Deafness |
5.6% |
| Melaena |
5.6% |
| Small Intestinal Haemorrhage |
5.6% |
| Stevens-johnson Syndrome |
5.6% |
| Toxic Epidermal Necrolysis |
5.6% |
| Hypoglycaemia |
3.7% |
| Off Label Use |
3.7% |
| Post Procedural Haemorrhage |
3.7% |
| Skin Exfoliation |
3.7% |
| Subarachnoid Haemorrhage |
3.7% |
| Subcutaneous Haematoma |
3.7% |
| Tumour Haemorrhage |
3.7% |
| Uterine Haematoma |
3.7% |
| Wrong Drug Administered |
3.7% |
| Angioedema |
1.9% |
| Coronary Artery Stenosis |
1.9% |
|
| Secondary |
| Hypertension |
20.2% |
| Product Used For Unknown Indication |
12.0% |
| Prophylaxis |
8.6% |
| Myocardial Infarction |
5.8% |
| Cardiac Failure |
5.3% |
| Acute Coronary Syndrome |
4.6% |
| Atrial Fibrillation |
4.4% |
| Diabetes Mellitus |
4.4% |
| Hyperlipidaemia |
4.1% |
| Angina Pectoris |
3.4% |
| Cerebral Infarction |
3.4% |
| Hyperphosphataemia |
3.2% |
| Type 2 Diabetes Mellitus |
3.1% |
| Constipation |
2.7% |
| Coronary Artery Disease |
2.7% |
| Insomnia |
2.7% |
| Trigeminal Neuralgia |
2.5% |
| Acute Myocardial Infarction |
2.4% |
| Thrombosis Prophylaxis |
2.4% |
| Pain |
2.2% |
|
| Pneumonia |
10.6% |
| Shock Haemorrhagic |
9.1% |
| Cerebral Haemorrhage |
7.6% |
| Subarachnoid Haemorrhage |
7.6% |
| Thrombocytopenia |
7.6% |
| Mallory-weiss Syndrome |
6.1% |
| Upper Gastrointestinal Haemorrhage |
6.1% |
| Interstitial Lung Disease |
4.5% |
| Melaena |
4.5% |
| Pyrexia |
4.5% |
| Vascular Graft |
4.5% |
| Adenocarcinoma Gastric |
3.0% |
| Cerebral Infarction |
3.0% |
| Drug Ineffective |
3.0% |
| Face Injury |
3.0% |
| Gastrointestinal Haemorrhage |
3.0% |
| Hepatic Function Abnormal |
3.0% |
| Jaundice Cholestatic |
3.0% |
| Oesophageal Ulcer Haemorrhage |
3.0% |
| Pain In Extremity |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.3% |
| Hypertension |
12.5% |
| Prophylaxis |
12.2% |
| Angina Pectoris |
4.8% |
| Diabetes Mellitus |
4.7% |
| Cardiac Failure |
4.4% |
| Chronic Hepatitis C |
3.9% |
| Rheumatoid Arthritis |
3.7% |
| Type 2 Diabetes Mellitus |
3.1% |
| Thrombosis Prophylaxis |
3.1% |
| Cerebral Infarction |
2.9% |
| Nephrogenic Anaemia |
2.8% |
| Constipation |
2.7% |
| Insomnia |
2.7% |
| Hyperlipidaemia |
2.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.3% |
| Multiple Myeloma |
2.1% |
| Atrial Fibrillation |
2.1% |
| Plasma Cell Myeloma |
2.0% |
| Myocardial Infarction |
1.9% |
|
| White Blood Cell Count Decreased |
9.8% |
| Renal Impairment |
9.6% |
| Vomiting |
8.7% |
| Cerebral Infarction |
7.9% |
| Interstitial Lung Disease |
7.9% |
| Rhabdomyolysis |
5.3% |
| Renal Disorder |
5.1% |
| Pneumonia |
4.8% |
| Rash |
4.8% |
| Sepsis |
3.9% |
| Hepatic Function Abnormal |
3.7% |
| Myocardial Infarction |
3.7% |
| Loss Of Consciousness |
3.4% |
| Renal Failure Acute |
3.4% |
| Urinary Tract Infection |
3.4% |
| Death |
3.1% |
| Pyrexia |
3.1% |
| Somnolence |
3.1% |
| Liver Disorder |
2.8% |
| Platelet Count Decreased |
2.8% |
|
| Interacting |
| Atrial Fibrillation |
11.7% |
| Cerebrovascular Accident Prophylaxis |
11.7% |
| Hypertension |
11.7% |
| Myocardial Infarction |
11.7% |
| Thrombosis Prophylaxis |
10.3% |
| Arterial Catheterisation |
8.3% |
| Peripheral Arterial Occlusive Disease |
8.3% |
| Stent Placement |
8.3% |
| Cerebral Infarction |
6.9% |
| Product Used For Unknown Indication |
3.4% |
| Anaemia |
1.4% |
| Benign Prostatic Hyperplasia |
0.7% |
| Brain Stem Haemorrhage |
0.7% |
| Cardiac Failure |
0.7% |
| Dementia Alzheimer's Type |
0.7% |
| Diabetes Mellitus |
0.7% |
| Gastric Ulcer |
0.7% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Ischaemic Heart Disease Prophylaxis |
0.7% |
| Prophylaxis |
0.7% |
|
| Haemorrhagic Cerebral Infarction |
24.0% |
| Vascular Pseudoaneurysm |
24.0% |
| Drug Interaction |
8.0% |
| Occult Blood Positive |
8.0% |
| Brain Stem Haemorrhage |
4.0% |
| Gastrointestinal Haemorrhage |
4.0% |
| Haemoptysis |
4.0% |
| Haemorrhage |
4.0% |
| Lower Gastrointestinal Haemorrhage |
4.0% |
| Melaena |
4.0% |
| Pulmonary Alveolar Haemorrhage |
4.0% |
| Subarachnoid Haemorrhage |
4.0% |
| Upper Gastrointestinal Haemorrhage |
4.0% |
|
